Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Case ReportCase Reports

A Case of Teeth Discoloration Upon Transition From Zyprexa to Generic Olanzapine

David Galarneau
Ochsner Journal December 2013, 13 (4) 550-552;
David Galarneau
Department of Psychiatry, Ochsner Clinic Foundation, and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

REFERENCES

  1. ↵
    1. U.S. Food and Drug Administration Center for Drug Evaluation and Research
    (2009) Approved Drug Products with Therapeutic Equivalence Evaluations. 29th ed (U.S. Department of Health & Human Resources, Silver Spring, MD).
  2. ↵
    1. Weinberg MA
    (2009) How is the quality of a generic drug evaluated. US Pharm Generic Drug Review 34(6):31–38, suppl):.
    OpenUrl
  3. ↵
    1. Brownlee CL
    (2002) Adding that “spoonful of sugar” - and more. Modern Drug Discovery 5(5):34–36, 38.
    OpenUrl
  4. ↵
    1. Lamy PP
    (May-Jun 1986) Generic equivalents: issues and concerns. J Clin Pharmacol 26(5):309–316, pmid:3700686.
    OpenUrlPubMed
  5. ↵
    1. Keen PJ
    (6, 1991) Innovative versus generic medicines. J R Soc Med 84(6):375–378.
    OpenUrlCrossRef
  6. ↵
    1. Moris TC,
    2. Lang HJ
    (1998) Innovative versus generic medicines. European Patent Application 0 830 858 A1;.
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 13, Issue 4
Dec 2013
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Case of Teeth Discoloration Upon Transition From Zyprexa to Generic Olanzapine
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Case of Teeth Discoloration Upon Transition From Zyprexa to Generic Olanzapine
David Galarneau
Ochsner Journal Dec 2013, 13 (4) 550-552;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Case of Teeth Discoloration Upon Transition From Zyprexa to Generic Olanzapine
David Galarneau
Ochsner Journal Dec 2013, 13 (4) 550-552;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • CASE REPORT
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Cited By...

  • Recent Publications by Ochsner Authors: October 2013 - March 2014
  • Google Scholar

More in this TOC Section

  • Propofol Infusion Syndrome or Not? A Case Report
  • Recurrent Angiomatoid Fibrous Histiocytoma: A Case Report and Review of the Literature
  • Late Recurrence of Light Chain Deposition Disease after Kidney Transplantation Treated with Bortezomib: A Case Report
Show more Case Reports

Similar Articles

Keywords

  • Drug toxicity
  • drugs—generic
  • psychotropic drugs

Current Post at the Blog

No Author Credit for ChatGPT

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2023 Ochsner Clinic Foundation

Powered by HighWire